FDA Adverse Event Injury Summary report: N

DAVINCI XI

MDR report key: 24518866 · Received March 5, 2026

Report

Report Number
2955842-2026-15083
Event Type
Injury
Date Received
March 5, 2026
Date of Event
February 7, 2026
Report Date
March 5, 2026
Manufacturer
INTUITIVE SURGICAL, INC
Product Code
NAY
UDI-DI
00886874110720
PMA / PMN Number
K131861
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WAS NO REPORT THAT A DA VINCI SYSTEM, INSTRUMENT OR ACCESSORY MALFUNCTIONED DURING THE PROCEDURE. ADDITIONAL PATIENT INFORMATION: HEIGHT 192 CM., BODY MASS INDEX (BMI) 26.9KG/M2. A REVIEW OF THE EVENT WAS PERFORMED BY AN INTUITIVE SURGICAL, INC. (ISI) SURGICAL MEDICAL SAFETY OFFICER (MSO). "THE PATIENT IN THIS REPORT UNDERWENT A PANCREATICODUODENECTOMY FOR PANCREATIC CANCER AND HAD A COMPLICATION OF A FLUID COLLECTION REQUIRING IR DRAINAGE. THIS COMPLICATION IS NOT RELATED TO THE JURA DEVICE NOR THE JURA PROCEDURE. MULTIPLE COMPLICATIONS ARE WELL KNOWN TO OCCUR AFTER A PANCREATICODUODENECTOMY INCLUDING SURGICAL SITE INFECTION (23%), FISTULA FORMATION (21%), ACCUMULATION OF FLUID COLLECTIONS (12%), AMONG OTHERS. (REF 1). WHILE THE EXACT CAUSE OF THIS FLUID COLLECTION IS NOT PROVIDED, THERE IS A CAUSAL RELATIONSHIP BETWEEN THIS COMPLICATION AND A PANCREATICODUODENECTOMY PROCEDURE. THERE IS NO EVIDENCE THIS COMPLICATION WAS RELATED TO THE DA VINCI DEVICE." REF 1. F. KARIM SAM, ABDULLA KS, ABDULKARIM QH, RAHIM FH. THE OUTCOMES AND COMPLICATIONS OF PANCREATICODUODENECTOMY (WHIPPLE PROCEDURE): CROSS SECTIONAL STUDY. INT J SURG. 2018 APR;52:383-387. DOI: 10.1016/J.IJSU.2018.01.041. EPUB 2018 FEB 10. PMID: 29438817.

Description of Event or Problem · 0

A PATIENT IN A STUDY UNDERWENT A DA VINCI AND JURA SYSTEM-ASSISTED PANCREATICODUODENECTOMY SURGICAL PROCEDURE. FOUR DAYS AFTER DISCHARGE, THE PATIENT PRESENTED AT THE EMERGENCY DEPARTMENT WITH A PANCREATIC FISTULA AND AN ABSCESS AT THE PANCREAS ANASTOMOSIS (PANCREATICOJEJUNOSTOMY) WHICH WAS FOLLOWED BY READMISSION AND INITIATION OF ANTIBIOTICS (CEFTRIAXONE AND METRONIDAZOLE). TWO DAYS LATER, CIPROFLOXACIN WAS STARTED AND A RADIOLOGICAL DRAINAGE AND FLUID COLLECTION WAS PERFORMED. LABS AND CULTURE OF THE FLUID HAVE SHOWN HIGH AMYLASE AND BACTERIA SUPPORTING THE SUSPECTED FISTULA AND ABSCESS, RESPECTIVELY. THE EVENT HAS BEEN REPORTED AS RESOLVED THIRTEEN DAYS AFTER ADMISSION. THE INDEX PROCEDURE WAS COMPLETED WITHOUT INTRAOPERATIVE COMPLICATIONS; NO MALFUNCTIONS WERE REPORTED WITH THE DA VINCI SYSTEM, ITS INSTRUMENTS OR ACCESSORIES, OR THE JURA SYSTEM. DISCHARGE OCCURRED SIX DAYS AFTER THE SURGICAL PROCEDURE. THE STUDY INVESTIGATOR REPORTED THE EVENT AS MODERATE SEVERITY, A SERIOUS ADVERSE EVENT (REQUIRING HOSPITALIZATION), A CLAVIEN-DINDO GRADE IIIA, NOT RELATED TO THE STUDY PROCEDURE, NOT RELATED TO THE JURA SYSTEM, NOT RELATED TO THE DA VINCI SYSTEM, BUT POSSIBLY RELATED TO THE PATIENT'S UNDERLYING DISEASE STATUS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
583306 DAVINCI XI PATIENT SIDE CART, 4-ARM NAY INTUITIVE SURGICAL, INC 380652-39 N/A 00886874110720

Patients

Seq Age Sex Outcome Treatment
1 60 YR Male Hospitalization| R DA VINCI INSTRUMENTS AND ACCESSORIES.